Retraction
Effect of Yiqi Huayu Pinggan Zishen Formula Combined with Valsartan in the Treatment of Hypertension and Its Effect on MMP-9, Ang II, and MCP-1
Paper Information
Record ID:
47889
Author(s):
Publication Date:
May 06, 2022
Retraction Date:
July 19, 2023
(2.3 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institution:
Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, Sichuan Province, ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9819575Additional Notes:
See also: https://pubpeer.com/publications/0A6DEFC5C1DE7C4DF8BA9741C0579E
Citations (3)
3
Total Citations0
Post-Retraction2
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Bioequivalência de duas formulações de Valsartana 320mg comprimido revestido em participantes sadios de ambos os sexos em condição de jejum
Paulo Alexandre Rebelo Galvinas, Paulo Alexandre Rebelo Galvinas, Carlos Sverdloff et al. (7 authors)
Brazilian Journal of Health Review
Open Access
Published: May 2023
75 days before retraction
Retracted: Effect of Yiqi Huayu Pinggan Zishen Formula Combined with Valsartan in the Treatment of Hypertension and Its Effect on MMP‐9, Ang II, and MCP‐1
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Open Access
Published: Jan 2023
199 days before retraction
Quick Stats
Total Citations:
3
Years Since Retraction:
2.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025